SPECT/CT imaging is a very promising technique for insulinoma localization, and uses radionuclide-labeled glucagon-like peptide-1 receptor agonist (GLP-1RA) to bind to glucagon-like peptide-1 receptor (GLP-1R) for radionuclide imaging. This evidence concerns the gene GLP1R and pancreatic insulinoma.